Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-222-2 | CAS number: 1115-20-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral: LD50 (rat) = 8000 mg/kg bw
inhalation risk test: no mortality
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study is comparable to OECD Guideline 401 with acceptable restrictions (partly limited documentation, e.g. no details about the test substance; post exposure observation period 7 days)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Mean body weight at initiation: 180-208g (males), 144-170g (females)
No further details. - Route of administration:
- oral: gavage
- Vehicle:
- other: aqueous suspension with 0.5% carboxymethylcellulose
- Details on oral exposure:
- concentration in test solution 35%; application volume 28.5 or 13.3 ml/kg bw, respectively; no data about fasting prior to application.
- Doses:
- 4640 or 10000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations:daily
- weighing: day 0, 2, or 7
- Necropsy of survivors and rats found dead - Statistics:
- no data
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 8 000 mg/kg bw
- Remarks on result:
- other: for males and females combined
- Mortality:
- Data on mortality are presented in the Table below. At the high dose levels rats died within 4 h as well as one female at the low dose level. Females more susceptible than males.
- Clinical signs:
- other: Clinical signs in both dose groups: immediately after gavage prone and side position, apathy, atony, gasping, cyanosis; 2nd day red encrusted noses; symptoms still present after 2 days. No symptoms detected 5 days after application.
- Gross pathology:
- Surviving rats: darkened liver and some cases of splenomegaly.
Rats found dead: dilatation of the heart; hyperemia - Other findings:
- no data
- Conclusions:
- The oral LD50 is 8000 mg/kg bw in male and female rats combined.
- Executive summary:
The study is comparable to OECD Guideline 401 with acceptable restrictions (partly limited documentation, e.g. no details about the test substance; post exposure observation period 7 days)
Groups of 5 male and 5 female rats were gavaged with 35% aqueous suspension at dose levels of 4640 and 10000 mg/kg bw. The post exposure observation period was 7 days. Clinical signs occurred immediately after gavage: prone and side position, apathy, atony, gasping, cyanosis, and 2nd day red encrusted noses; symptoms were still present after 2 days. No symptoms were detected 5 days after application.. Generally, females were more susceptible than males. The body weight gain was not reduced. Necropsy revealed dilatated heart and some cases of splenomegaly.
Conclusion: The oral LD50 is 8000 mg/kg bw in male and female rats combined.
Reference
Mortality in male and female rats after gavage; observation period 7 days
Dose in mg/kg bw | Males | Females |
4640 | 0/5 | 1/5 |
10000 | 3/5 | 4/5 |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 8 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- The test demonstrates that there is no relevant acute inhalation risk, when handling the substance without extensive dust formation. How ever the tes system is unsuitable concerning information going beyond this statement. Acute inhalation toxicity test with dust enriched atmosphere; 8 h whole body exposure; one estimated dose of 0.04 mg/l.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Rats are exposed for 8 h in a dust enriched atmosphere, generated by leading the air though an about 5 cm thick substance layer. Post exposure period is 7 days.
- GLP compliance:
- no
- Test type:
- other: acute inhalation hazard test
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- At initiation the age was unknown and mean weight of males was 174 g and of females 156 g
no further data - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: air
- Details on inhalation exposure:
- Dust was generated by bubbling 200 l/h dry air (no CO2) through the solid substance column (volume ca. 50 ml) of about 5 cm above a fritted glass disc in a glass cylinder at a temperature of 20°C.
- Analytical verification of test atmosphere concentrations:
- not specified
- Duration of exposure:
- 8 h
- Concentrations:
- Estimation of concentration from the amount of TS consumed and the air volume: 0.04 mg/l. No further details.
- No. of animals per sex per dose:
- 6 rats per sex exposed for 8 h. Controls: 3 males and 3 females.
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 7 days
- Frequency of observations: daily
- Weighing: at initiation and at termination
- Necropsy performed of survivors and rats found dead
- Other examinations performed: clinical signs - Statistics:
- no data
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- 0.04 mg/L air (nominal)
- Exp. duration:
- 8 h
- Remarks on result:
- other: dust; estimated concentration
- Mortality:
- No mortality
- Clinical signs:
- other: No clinical signs
- Body weight:
- Normal; compared to controls
- Gross pathology:
- No effects detected.
- Other findings:
- No effects in controls exposed to air.
- Conclusions:
- In the inhalation hazard test no effects were detected in male and female rats after exposure to dust for 8 h at 20°C.
- Executive summary:
The acute inhalation toxicity test is an unsuitable test system due to the atmosphere generation, the estimation of the exposure concentration, the exposure time and the short post exposure observation period.
Rats were exposed for 8 h to dust generated at 20°C (estimated concentration: 0.04 mg/l). The mortality rate was 0/6 in males and 0/6 in females. No clinical signs were observed during and after exposure. Necropsy after 7 days revealed no treatment related effects.
Conclusion: In the inhalation hazard test no effects were detected in male and female rats after exposure to dust for 8 h at 20°C.
Reference
Authors estimation of the exposure concentration presumably via measurement of test substance weight.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating conc.
Additional information
ORAL:
The study (BASF AG, 1974) is comparable to OECD Guideline 401 with acceptable restrictions (partly limited documentation, e.g. no details about the test substance; post exposure observation period 7 days). Groups of 5 male and 5 female rats were gavaged with 35 % aqueous HPN (CAS 1115 -20 -4) at dose levels of 4640 and 10000 mg/kg bw with a post exposure observation period of 7 days. Clinical signs occurred immediately after gavage: prone and side position, apathy, atony, gasping, cyanosis, and 2nd day red encrusted noses; symptoms were still present after 2 days. No symptoms were detected 5 days after application. Generally, females were more susceptible than males. The body weight gain was not reduced. Necropsy revealed dilatated heart and some cases of splenomegaly. The oral LD50 is 8000 mg/kg bw in male and female rats combined.
INHALATION:
In the available acute inhalation toxicity test (BASF test, 1974) for HPN (CAS 1115 -20 -4) rats were exposed for 8h to HPN dust, generated at 20 °C (estimated concentration 0.05 mg/L). The mortality rate was 0/6 in males and 0/6 in females. No clinical signs were observed during and after exposure. Necropsy after 7 days revealed no treatment related effects. The test demonstrates that there is no relevant acute inhalation risk, when handling the substance without extensive dust formation. However the test system is unsuitable concerning information going beyond this statement.
Justification for classification or non-classification
Due to the results from the acute toxicity studies, classification and labelling according to Annex VI of Directive 67/548/EWG or Annex I of Directive 1272/2008 (EU-GHS) is not required for HPN (= 3-hydroxy-2,2-dimethyl-propyl- 3'-hydroxy-2',2'dimethylpropionate), because - if mortality was observed - it occured above threshold for classification and labeling.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.